Markus John, M.D.

CMO in Venture Capital | senior R&D leader in big pharma | non executive board member in biotech | founder of steerBIO R&D consulting

22 years of strategic, global leadership experience in biopharma, venture capital and boards. Covering the entire discovery and development lifecycle while being integrated with commercial and market access strategies: Partnering, Medical Affairs, Clinical Development, Translational Medicine, Discovery Research and Diagnostics. Academic and clinical training in internal medicine & endocrinology at MGH/Harvard and Heidelberg University Hospital.

Experienced in multiple therapeutic areas, indications, product launches and treatment modalities: incl. immunology, ophthalmology, oncology and rare diseases; small molecules, biologics, gene therapy and cell-based therapies. Well published with an h-index of 24.

Trying to serve patient needs from whatever part of the ecosystem I am involved in.